Effect of Cilostazol on platelet activation in pateints with type 2 diabetes mellitus
Not Applicable
- Conditions
- type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000004373
- Lead Sponsor
- Internal medicine, Shiga University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) diabetic patients except type 2 diabetes 2) patients below 20 years of age 3) pregnant pateints or the lactation period 4) complicated with malignacy, liver disease and collagen disease 5) taking any NSAIDs within 2 weeks 6) past history of bleeding within 6 weeks or bleeding tendency 7) complicated with sever coronary stenosis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) the formation of spontaneous maicro-aggregation of platelet (SMAP) 2) the expression levels of active GPIIb/IIIa and P-selectin on the platelet
- Secondary Outcome Measures
Name Time Method